Beta Bionics (Nasdaq:BBNX) announced today that it launched Bionic Insights, a new feature for healthcare providers and ...

Irvine-based Beta Bionics, which recently went public, saw two-year revenue increase more than eight-fold to $103.2 million.

IRVINE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Beta Bionics today announced the launch of Bionic Insights™ , an innovative new feature within its Bionic Reports, designed to help healthcare ...

Add Yahoo as a preferred source to see more of our stories on Google. Beta Bionics said it plans to integrate its ILet Bionic Pancreas automated insulin delivery system with a glucose-ketone sensor ...

Artificial pancreas systems synchronize an insulin pump and continuous glucose monitor with the goal of delivering an almost completely hands-off approach to diabetes management—and the newest one ...

The following is the third part of a series on brain-machine integration and biomechanical solutions to restore function to tissues damaged by disease, trauma, or time. The FDA recently granted ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

In the wake of earning FDA clearance for its insulin pump and automated dosing software—which connect to a Dexcom continuous glucose monitor to create what’s known as a hybrid closed-loop system for ...

Patch pump under development with commercialization expected by the end of 2027 One of Orange County’s fastest-growing public companies only went public two months ago. Beta Bionics Inc.’s concept of ...

Beta Bionics today announced the launch of Bionic Insights™, an innovative new feature within its Bionic Reports, designed to help healthcare providers ...